AirSculpt Technologies, Inc.

AIRS

US0094961002

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-05 EDT			5-day change	1st Jan Change
4.25 ^USD	+2.41%		-6.18%	-43.26%

05-14	Leerink Partners Downgrades AirSculpt Technologies to Market Perform From Outperform, Price Target is $5	MT
05-13	Raymond James Downgrades AirSculpt Technologies to Market Perform From Outperform	MT

AirSculpt Technologies, Inc. Provides Earnings Guidance for the Fiscal Year 2021

December 03, 2021 at 06:00 am

AirSculpt Technologies, Inc. provided earnings guidance for the fiscal year 2021. The company projects full year revenue to be approximately $130 million.

Latest news about AirSculpt Technologies, Inc.

Leerink Partners Downgrades AirSculpt Technologies to Market Perform From Outperform, Price Target is $5	05-14	MT
Raymond James Downgrades AirSculpt Technologies to Market Perform From Outperform	05-13	MT
AirSculpt Technologies Shares Down After Q1 Adjusted Earnings Fall	05-10	MT
Transcript : AirSculpt Technologies, Inc., Q1 2024 Earnings Call, May 10, 2024	05-10
Earnings Flash (AIRS) AIRSCULPT TECHNOLOGIES Reports Q1 Revenue $47.6M	05-10	MT
AirSculpt Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-10	CI
AirSculpt Technologies, Inc. Maintains Earnings Guidance for the Full Year 2024	05-10	CI
Airsculpt Technologies, Inc. Announces the Relocation of Its Atlanta Office	04-29	CI
AirSculpt Technologies, Inc. Expands Its Scottsdale Location	03-04	CI
Transcript : AirSculpt Technologies, Inc., Q4 2023 Earnings Call, Feb 27, 2024	02-27
Earnings Flash (AIRS) AIRSCULPT TECHNOLOGIES Posts Q4 Revenue $47.6M	02-27	MT
Earnings Flash (AIRS) AIRSCULPT TECHNOLOGIES Reports Q4 EPS $0.01	02-27	MT
AirSculpt Technologies, Inc. Provides Revenue Guidance for the Full Year 2024	02-27	CI
AirSculpt Technologies, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-27	CI
AirSculpt Technologies Shares Slump After Report by Short-Seller Fuzzy Panda	02-23	MT
FUZZY PANDA RESEARCH: IS SHORT AIRSCULPT TECHNOLOGIES…	02-23	RE
Morgan Stanley Trims Price Target on AirSculpt Technologies to $6 From $8, Maintains Equalweight Rating	11-16	MT
Transcript : AirSculpt Technologies, Inc., Q3 2023 Earnings Call, Nov 10, 2023	11-10
North American Morning Briefing : Investors Weigh Higher-For-Longer Rates	11-10	DJ
Earnings Flash (AIRS) AIRSCULPT TECHNOLOGIES Reports Q3 Revenue $46.8M, vs. Street Est of $46.6M	11-09	MT
Earnings Flash (AIRS) AIRSCULPT TECHNOLOGIES Reports Q3 EPS $0.05, vs. Street Est of $0.09	11-09	MT
AirSculpt Technologies, Inc. Reconfirms Revenue Guidance for the Full Year 2023	11-09	CI
AirSculpt Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
AirSculpt Technologies, Inc. Revises Earnings Guidance for the Year 2023	23-10-05	CI
AirSculpt Technologies Opens New Location in North Carolina	23-09-18	MT

Chart AirSculpt Technologies, Inc.

Duration

Period

More charts

AirSculpt Technologies, Inc., through its wholly owned subsidiaries, is a provider of practice management services to professional associations (PAs) located throughout the United States, Canada, and the United Kingdom. The Company owns and operates non-clinical assets and provides its management services to the PAs through management services agreements (MSAs). Its direct medical procedure services segment. The Company offers fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patientâs own fat cells to enhance the breasts, buttocks, hips, or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. Its AirSculpt + procedure permanently removes fat and tightens the skin with unparalleled precision and finesse.

Sector

Healthcare Facilities & Services

Calendar

2024-08-08 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for AirSculpt Technologies, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

4.25 USD

Average target price

5 USD

Spread / Average Target

+17.65%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Doctor's Office

	1st Jan change	Capi.
AIRSCULPT TECHNOLOGIES, INC.	-43.26%	245M
HUAXIA EYE HOSPITAL GROUP CO.,LTD.	-22.19%	2.88B
TOPCHOICE MEDICAL CO., INC.	-18.00%	2.76B
EUROEYES INTERNATIONAL EYE CLINIC LIMITED	-3.65%	219M
MEDSCI HEALTHCARE HOLDINGS LIMITED	-46.54%	177M
AESTHETIC CONNECT	-32.96%	115M

Doctor's Office